Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

KMB

Market Inference Brief -- KMB Stock

Large-cap Consumer Discretionary company Kimberly-Clark has logged a -0.1% change today on a trading volume of 1,020,024. The average volume for the stock is 2,326,871.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. Based in Dallas, United States the company has 38,000 full time employees and a market cap of $44,415,229,952. Kimberly-Clark currently offers its equity investors a dividend that yields 3.7% per year.

The company is now trading -6.37% away from its average analyst target price of $142.96 per share. The 19 analysts following the stock have set target prices ranging from $118.0 to $162.0, and on average give Kimberly-Clark a rating of hold.

Over the last 12 months KMB shares have declined by -0.1%, which represents a difference of -11.0% when compared to the S&P 500. The stock's 52 week high is $150.45 per share and its 52 week low is $124.1. Based on Kimberly-Clark's average net margin growth of 0.9% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 20,058,000 2,545,000 13 44.44
2023 20,431,000 1,764,000 9 -10.0
2022 20,175,000 1,934,000 10 11.11
2021 19,440,000 1,814,000 9 -25.0
2020 19,140,000 2,352,000 12 0.0
2019 18,450,000 2,157,000 12
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS